LISATA THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
LISATA THERAPEUTICS, INC. (LSTA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2019-03-14
- LISATA THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LISATA THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $11.53M.
- LISATA THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- LISATA THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $17.24M, a 16448.17% increase from fiscal 2014.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2017-12-31 | $11.53M 10-K · filed 2019-03-14 | $11.53M 10-K · filed 2018-03-22 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | -$138.04K 10-K · filed 2017-03-17 |
| 2015-12-31 | $17.24M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $104.20K 10-K · filed 2016-03-15 | |
| 2013-12-31 | -$780.10K 10-K · filed 2016-03-15 | |
| 2012-12-31 | $175.53K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |